Completed PHASE2 INTERVENTIONAL 1-arm NCT00471848

Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia (RATGAA07)

Prospective Phase II Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline®, Genzyme) With Ciclosporin for Patients With Acquired Aplastic Anaemia and Comparison With Matched Historical Patients Treated With Horse ATG and Ciclosporin

Sponsor: European Society for Blood and Marrow Transplantation

Conditions Aplastic Anemia

Interventions rabbit antithymocyte globulin

Updated 10 times since 2017 Last updated: Sep 7, 2023 Started: Aug 31, 2008 Primary completion: Oct 31, 2011 Completion: Feb 28, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00471848, this PHASE2 trial focuses on Aplastic Anemia and remains completed. Sponsored by European Society for Blood and Marrow Transplantation, it has been updated 10 times since 2008, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Oct 2023 — Jul 2024 [monthly]

Completed PHASE2
Jan 2023 — Oct 2023 [monthly]

Completed PHASE2

▶ Show 5 earlier versions

Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Nov 2021 — Dec 2022 [monthly]

Completed PHASE2

Status: Unknown Status → Completed
Jan 2021 — Nov 2021 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Society for Blood and Marrow Transplantation
Genzyme, a Sanofi Company

Data source: European Society for Blood and Marrow Transplantation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Basel, Switzerland , Bournemouth, United Kingdom , Cambridge, United Kingdom , Créteil, France , Essen, Germany , Genova, Italy , Hamburg, Germany , Hanover, Germany , London, United Kingdom , Nottingham, United Kingdom and 3 more locations